Search research articles
Contact Us
Filters
Showing results (121-130 of 126) with videos related to
Page
of 13
Sort By:
You have reached the last page of results.
This site can display upto 126 results.
Cancer Chemotherapy and Pharmacology
|
January 6, 2004
The development of targeted chemotherapy for CNS lymphoma-a pilot study of the IDARAM regimen
P Moreton, G J Morgan, D Gilson, et al.
Immunogenetics
|
August 29, 2009
Mortality in adult intensive care patients with severe systemic inflammatory response syndromes is strongly associated with the hypo-immune TNF -238A polymorphism
John V Pappachan, Tim G Coulson, Nicholas J A Child, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 29, 1998
Five-year follow-up of a prospective randomised multi-centre trial of weekly chemotherapy (CAPOMEt) versus cyclical chemotherapy (CHOP-Mtx) in the treatment of aggressive non-Hodgkin's lymphoma. Central Lymphoma Group
N P Bailey, N S Stuart, E M Bessell, et al.
Hematological Oncology
|
October 12, 2000
Positive and negative selection to reduce tumour contamination in peripheral blood stem cell harvests
F E Davies, A C Rawstron, G Pratt, et al.
Leukemia
|
August 13, 2011
A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial
K D Boyd, F M Ross, L Chiecchio, et al.
Lancet (London, England)
|
July 31, 2007
Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial
D Catovsky, S Richards, E Matutes, et al.
Page
of 13
Search research articles
Search
Showing results (121-130 of 126) with videos related to
Sort By:
Page
of 13
You have reached the last page of results.
This site can display upto 126 results.
Cancer Chemotherapy and Pharmacology
|
January 6, 2004
The development of targeted chemotherapy for CNS lymphoma-a pilot study of the IDARAM regimen
P Moreton, G J Morgan, D Gilson, et al.
Immunogenetics
|
August 29, 2009
Mortality in adult intensive care patients with severe systemic inflammatory response syndromes is strongly associated with the hypo-immune TNF -238A polymorphism
John V Pappachan, Tim G Coulson, Nicholas J A Child, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 29, 1998
Five-year follow-up of a prospective randomised multi-centre trial of weekly chemotherapy (CAPOMEt) versus cyclical chemotherapy (CHOP-Mtx) in the treatment of aggressive non-Hodgkin's lymphoma. Central Lymphoma Group
N P Bailey, N S Stuart, E M Bessell, et al.
Hematological Oncology
|
October 12, 2000
Positive and negative selection to reduce tumour contamination in peripheral blood stem cell harvests
F E Davies, A C Rawstron, G Pratt, et al.
Leukemia
|
August 13, 2011
A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial
K D Boyd, F M Ross, L Chiecchio, et al.
Lancet (London, England)
|
July 31, 2007
Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial
D Catovsky, S Richards, E Matutes, et al.
Page
of 13